MarketInOut Stock Screener Log In | Sign Up

Psomagen Inc

KRX • Healthcare • Diagnostics & Research • Quote as of 10/28/2026 15:30
Psomagen Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeKRX
Market Capitalization54,823 mln
Float8.28 mln
Earnings Date08/18/2025

EPS

123
Exceptional

P / E

24.00
Premium valuation

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-2.6
Likely reliable

Relative Strength

84 / 100
Strongly outperforming

Debt / Equity

0.31
Low leverage

Business Description

Psomagen Inc. is a Delaware-based laboratory services company that helps researchers and clinicians understand the biology of living organisms through advanced genetic and molecular analysis. The company offers a broad range of scientific services, including the study of genes, proteins, RNA, and microbial communities, as well as tools that help scientists make sense of complex biological data. Psomagen also provides clinical genetic testing using several sequencing methods to support medical diagnosis and research. Founded in 2004 and formerly known as Macrogen Corp., the company operates as a subsidiary of South Korea-based Macrogen Inc.

Key Fundamentals

EPS123
P/E24.00
ROE9.00
RPS3,029
ROIC-2.18
ROA4.86
EBITDA, mln4,374
EV / EBITDA12.09
EV / EBIT-87.50
Revenue, mln57,163
EV / Revenue0.93

Quote Details

Last 2,965.00
Change 130 (4.59%)
Open 2,875.00
Volume 492,141
Turnover 1,459,198,080
Average Volume 75,329

Financial Ratios

Pre-Tax Profit Margin-3
Current Ratio2.45
Price / Book1.85
Price / Tangible Book2.22
Price / Free Cash Flow14.35
Debt / Equity0.31
Price / Sales1.04

Financial Strength

Altman Z-Score3.69
Piotroski F-Score 9 / 9
Beneish M-Score-2.6
Price to Graham Number1.58

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.66% 51 / 100   
1 Month -4.82% 56 / 100   
2 Months 10.02% 83 / 100   
6 Months -23.88% 49 / 100   
1 Year -19.86% 41 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog